Trending

pharma R&D

Jay Bradner: leading Novartis into age of digitally-enabled discovery

Jay Bradner: leading Novartis into age of digitally-enabled discovery

Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into ‘a medicine and data science company’.

X

Jay Bradner: leading Novartis into age of digitally-enabled discovery

https://pharmaphorum.com/views-analysis-digital/jay-bradner-leading-novartis-age-digitally-enabled-discovery/

How AI, blockchain, and big data can reduce drug development costs

How AI, blockchain, and big data can reduce drug development costs

Cutting-edge technologies are increasingly improving pharma’s R&D processes.

X

How AI, blockchain, and big data can reduce drug development costs

https://pharmaphorum.com/views-and-analysis/ai-blockchain-big-data-can-reduce-drug-development-costs/

Pharma R&D is crying out for disruption – is AI the answer?

Pharma R&D is crying out for disruption – is AI the answer?

Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.

X

Pharma R&D is crying out for disruption – is AI the answer?

https://pharmaphorum.com/r-d/views-analysis-r-d/ai-pharma-rd-disruption/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com